title: [Virostatic treatment of herpes simplex infections of variable severity].
abstract: Aciclovir (ACV) is the most effective drug for the virostatic management of herpes simplex virus (HSV) infections, and the rate of side-effects is low. ACV resistance is rare, occurring only in highly immunocompromised patients (so far about 30 cases have been reported). Dosages and modes of application of ACV in different HSV infections are indicated and discussed.
authors: Ludwig Boltzmann-Institut zur Erforschung infektiöser venero-dermatologischer Erkrankungen Wien.
authors: R
authors: R
authors: Raab
authors: J
authors: J
authors: Söltz-Szöts
mesh_terms: D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004485:Eczema / Q000188:drug therapy; D004660:Encephalitis / Q000188:drug therapy; D006558:Herpes Genitalis / Q000188:drug therapy; D006560:Herpes Labialis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir
vernacular_title: Virustatische Behandlung von Herpes simplex-Infektionen unterschiedlicher Verlaufsschwere.